EDIT

Editas Medicine, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$2.14

Price (1 Year)

$3.65 $1.76

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %16.2 / %30
Non-compliant assets / Total market cap %54.9 / %30
Non-compliant revenue / Total income %15.3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology.

Website

Analysis (Turkish): EDIT Hissesi Caiz mi, Helal mi? Editas Medicine, Inc. Katılım Analizi